Alex Soros meets Muhammad Yunus: How is Bangladesh’s interim chief connected to Soros family

Alex Soros meets Muhammad Yunus: How is Bangladesh’s interim chief connected to Soros family

Related:

The DAC Network on Poverty Reduction is a community of the OECD that aims to help donor agencies and developing country governments focus on poverty reduction

Google

Grameen America’s Institutional Partners

U.S. Department of Treasury’s Community Development Financial Institutions Fund (CFI Fund), Dalio Foundation, Jennifer & Jonathan Allan Soros Foundation (George Soros’ son), U.S. Small Business Administration, etc.

Bangladesh document

US military, seeking strategic advantages, builds up Australia’s northern bases amid China tensions

Source

DARWIN, July 26 (Reuters) – The U.S. military is building infrastructure in northern Australia to help it project power into the South China Sea if a crisis with China erupts, a Reuters review of documents and interviews with U.S. and Australian defence officials show.

US military, seeking strategic advantages, builds up Australia’s northern bases amid China tensions

Related:

US military eyes Australia’s Indian Ocean toehold to deter China

SYDNEY – A remote Australian island close to an Indian Ocean chokepoint for Chinese oil shipments is on a list of possible locations for US military construction aimed at deterring China, with the US saying it “may or may not” support American forces.

Australian-based Marines ready to support Manila in sea-territory skirmish

Australian-based Marines ready to support Manila in sea-territory skirmish

Australian-based Marines ready to support Manila in sea-territory skirmish

“We were given a warning order to support the Philippines defense forces in resupplying of the Second Thomas Shoal,” Marine Rotational Force — Darwin commander Col. Brian Mulvihill told Stars and Stripes on Wednesday at an Outback training camp in the Northern Territory.

The Marines have been monitoring events at the shoal over a drone feed, Mulvihill said.

“We were ready to support the Philippine defense forces,” he said, noting that Marines across the Pacific are also ready to back the U.S. ally.

The rotational force can airlift food and water by pushing pallets out of helicopters, he added.

“We can control airspace and aircraft from many nations,” he said. “We provide a range of options if a host nation, through the embassy, requires assistance.”

Darwin is an excellent platform for launching forces into Southeast Asia, according to Grant Newsham, a retired Marine colonel and senior researcher with the Japan Forum for Strategic Studies in Tokyo. 

“It’s good to see Darwin and Northern Territory being used this way … rather than just as a training area for Marines, Air Force, and Australian and other forces,” he said by email Thursday.

The Marines can offer the Philippines fire support coordination. They can help with logistics and intelligence, surveillance and reconnaissance and guard locations that support Philippine forces operating towards the disputed shoal, he said.

“Of course, Marines can deploy aboard Philippine resupply boats alongside [Philippine] personnel,” he said.

Marine engineers could repair the Sierra Madre at the shoal and Marine helicopters could resupply it, Newsham added.

“A U.S. amphibious ship or two with Marines and their aircraft and other hardware aboard deployed to Second Thomas Shoal would be a serious force — and also sending a clear message,” he said. “Deploying Marines in the Philippines with their aviation, long-range rockets, and other hardware has a political significance in itself.”

Related:

Japan Forum for Strategic Studies

South China Sea: Philippines says to solely run Second Thomas Shoal resupply missions

SeaLight, formerly Project Myoushu

Alzheimer’s latest drug and science journalism’s memory problem

In July, the medical community was rocked by a disappointing reminder of science’s weakest link: the humans doing the work. The journal Science had shared that its six-month investigation supported the findings of whistleblower Matthew Schrag, who first noted altered images in a high-impact paper on Alzheimer’s, published in Nature in 2006. That paper is still flagged on Nature as under review, but the damage has already been done. Alzheimer’s drugs for the last decade and a half have been developed around claims without as much evidence as initially believed—which might also explain why they haven’t been working, leading people to pour false hope into useless and often expensive treatment plans for declining loved ones.

Alzheimer’s latest drug and science journalism’s memory problem

Why America Doesn’t Trust the CDC

Why America Doesn’t Trust the CDC

Most remarkably, it didn’t seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study that concluded in February. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.

Public health officials are expected to recommend COVID vaccines for children under 5 as soon as June 21st, despite the fact that the vast majority of children already have natural immunity. In a recent Kaiser survey, only 18 percent of parents said they were eager to vaccinate their child in that age group.

The FDA loves horse medicine if it’s really expensive, still under patent, and toxic (Fauci, Baric, Denison, DTRA & Gilead Sciences)

The FDA loves horse medicine if it’s really expensive, still under patent, and toxic

Related:

Study shows effectiveness of pill form of remdesivir to treat COVID-19 in mice (Ralph Baric & Gilead Sciences)**

Molnupiravir & Ivermectin’s Equine Connections

An emerging antiviral takes aim at COVID-19

[Molnupiravir] EIDD-2801’s story starts years before the coronavirus crisis. In 2014, Painter and his colleagues at Emory University began a project funded by the Defense Threat Reduction Agency to find an antiviral compound that could fight Venezuelan equine encephalitis virus (VEEV). During the Cold War, both the US and the Soviet Union studied VEEV as a potential biological weapon. Typically transmitted through mosquito bites, VEEV causes high fevers, headaches, and sometimes encephalitis, swelling of the brain that can be deadly.

In late 2019, Painter got a contract from the National Institute of Allergy and Infectious Diseases* to move EIDD-2801 into Phase I clinical trials for influenza. The plan was to file an investigational new drug application and find a partner to help with the clinical work.

Just as the team was contemplating its next move, word of a virus spreading in Wuhan, China, was starting to make news. One of Painter’s collaborators, UNC coronavirus expert Ralph Baric**, immediately alerted him that the new pathogen was probably a coronavirus—one that EIDD-2801 could potentially combat.

Denison*** says the research team knew a coronavirus outbreak was inevitable. “Every single one of our grants, every single one of our papers predicted that this event was going to happen that’s occurring right now,” he says. “The whole goal of our drug development was to plan for this.”

*Anthony Fauci, director of NIAID.

**Ralph Baric, patents.

***Mark Denison (Denison Lab/Vanderbilt University Medical Center & Gilead Sciences)